Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Carcinoma and NR1I2[original query] |
---|
Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Jun 29 (18): 2557-64. Xu Chun-Fang, Bing Nan X, Ball Howard A, Rajagopalan Dilip, Sternberg Cora N, Hutson Thomas E, de Souza Paul, Xue Zhengyu G, McCann Lauren, King Karen S, Ragone Leigh J, Whittaker John C, Spraggs Colin F, Cardon Lon R, Mooser Vincent E, Pandite Lini |
Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma. European journal of clinical pharmacology 2015 Sep . Diekstra Meta H M, Liu Xiaoyan, Swen Jesse J, Boven Epie, Castellano Daniel, Gelderblom Hans, Mathijssen Ron H J, Rodríguez-Antona Cristina, García-Donas Jesus, Rini Brian I, Guchelaar Henk-J |
Role of NR1I2 (pregnane X receptor) polymorphisms in head and neck squamous cell carcinoma. Naunyn-Schmiedeberg's archives of pharmacology 2015 Jul . Reuter Tasmin, Warta Rolf, Theile Dirk, Meid Andreas D, Rigalli Juan Pablo, Mogler Carolin, Herpel Esther, Grabe Niels, Lahrmann Bernd, Plinkert Peter K, Herold-Mende Christel, Dyckhoff Gerhard, Haefeli Walter Emil, Weiss Johan |
Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer chemotherapy and pharmacology 2017 Jul . Mbatchi Litaty C, Gassiot Matthieu, Pourquier Philippe, Goberna Alejando, Mahammedi Hakim, Mourey Loic, Joly Florence, Lumbroso Serge, Evrard Alexandre, Houede Nadi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: